The complexity of evaluating and increasing adherence in inflammatory bowel disease

Research output: Contribution to journalEditorialResearch

Standard

The complexity of evaluating and increasing adherence in inflammatory bowel disease. / Weimers, Petra; Burisch, Johan; Munkholm, Pia.

In: Revista Espanola de Enfermedades Digestivas, Vol. 109, No. 8, 2017, p. 539-541.

Research output: Contribution to journalEditorialResearch

Harvard

Weimers, P, Burisch, J & Munkholm, P 2017, 'The complexity of evaluating and increasing adherence in inflammatory bowel disease', Revista Espanola de Enfermedades Digestivas, vol. 109, no. 8, pp. 539-541. https://doi.org/10.17235/reed.2017.5143/2017

APA

Weimers, P., Burisch, J., & Munkholm, P. (2017). The complexity of evaluating and increasing adherence in inflammatory bowel disease. Revista Espanola de Enfermedades Digestivas, 109(8), 539-541. https://doi.org/10.17235/reed.2017.5143/2017

Vancouver

Weimers P, Burisch J, Munkholm P. The complexity of evaluating and increasing adherence in inflammatory bowel disease. Revista Espanola de Enfermedades Digestivas. 2017;109(8):539-541. https://doi.org/10.17235/reed.2017.5143/2017

Author

Weimers, Petra ; Burisch, Johan ; Munkholm, Pia. / The complexity of evaluating and increasing adherence in inflammatory bowel disease. In: Revista Espanola de Enfermedades Digestivas. 2017 ; Vol. 109, No. 8. pp. 539-541.

Bibtex

@article{b3310feeb64d4af6880688216344d8a9,
title = "The complexity of evaluating and increasing adherence in inflammatory bowel disease",
abstract = "Inflammatory bowel diseases (IBDs), due to their chronic and progressive nature, require lifelong treatment to relief and/or prevent inflammation and symptoms, obtaining mucosal healing at best. Therefore, adherence to treatment is an essential topic to address when treating patients with IBD. Nonetheless, adherence remains a common and complex issue in IBD care. Patient characteristics such as young age, male sex and employment has previously been verified as possible predictors of non-adherence. Additionally, evaluating adherence in itself is a challenge since both accurate and easy-to-use screening tools as well as golden standards are lacking.",
author = "Petra Weimers and Johan Burisch and Pia Munkholm",
year = "2017",
doi = "10.17235/reed.2017.5143/2017",
language = "English",
volume = "109",
pages = "539--541",
journal = "Revista Espanola de Enfermedades Digestivas",
issn = "1130-0108",
publisher = "ARAN Ediciones S.A.",
number = "8",

}

RIS

TY - JOUR

T1 - The complexity of evaluating and increasing adherence in inflammatory bowel disease

AU - Weimers, Petra

AU - Burisch, Johan

AU - Munkholm, Pia

PY - 2017

Y1 - 2017

N2 - Inflammatory bowel diseases (IBDs), due to their chronic and progressive nature, require lifelong treatment to relief and/or prevent inflammation and symptoms, obtaining mucosal healing at best. Therefore, adherence to treatment is an essential topic to address when treating patients with IBD. Nonetheless, adherence remains a common and complex issue in IBD care. Patient characteristics such as young age, male sex and employment has previously been verified as possible predictors of non-adherence. Additionally, evaluating adherence in itself is a challenge since both accurate and easy-to-use screening tools as well as golden standards are lacking.

AB - Inflammatory bowel diseases (IBDs), due to their chronic and progressive nature, require lifelong treatment to relief and/or prevent inflammation and symptoms, obtaining mucosal healing at best. Therefore, adherence to treatment is an essential topic to address when treating patients with IBD. Nonetheless, adherence remains a common and complex issue in IBD care. Patient characteristics such as young age, male sex and employment has previously been verified as possible predictors of non-adherence. Additionally, evaluating adherence in itself is a challenge since both accurate and easy-to-use screening tools as well as golden standards are lacking.

U2 - 10.17235/reed.2017.5143/2017

DO - 10.17235/reed.2017.5143/2017

M3 - Editorial

C2 - 28724305

VL - 109

SP - 539

EP - 541

JO - Revista Espanola de Enfermedades Digestivas

JF - Revista Espanola de Enfermedades Digestivas

SN - 1130-0108

IS - 8

ER -

ID: 195047482